Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-β1

Journal of Leukocyte Biology

Volumn 76, Issue 6, 2004, Pages 1220-1228

  McIntire, Ramsey H ^a   Morales, Pedro J ^a   Petroff, Margaret G ^a   Colonna, Marco ^b   Hunt, Joan S ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Human; Macrophage cytokines; Pregnancy immunology

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA G ANTIGEN; HLA G5 ANTIGEN; HLA G6 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN LIKE TRANSCRIPT 1; IMMUNOGLOBULIN LIKE TRANSCRIPT 4; IMMUNOGLOBULIN LIKE TRANSCRIPT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT HLA G5 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL INFILTRATION; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTROPHOBLAST; DECIDUA; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MYELOMONOCYTIC CELL; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; UTERUS;

ANTIGENS, CD; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-10; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MONOCYTES; PREGNANCY; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, IMMUNOLOGIC; RECOMBINANT FUSION PROTEINS; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; U937 CELLS;

EID: 10044273241     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0604337     Document Type: Article

References (54)

1. Hunt, J., Johnson, P. M. (1999) Immunology of reproduction. In Encyclopedia of Reproduction, vol. 2 (E. Knobil, J. D. Neill, eds.), London, UK, Academic, 798-806.
2. Hunt, J., Petroff, M. G. (2003) Placental immunology. In Encyclopedia of Hormones, vol. 3 (H. Henry, A. W. Norman, eds.), London, UK, Academic, 224-231.
3. Marzi, M., Vigano, A., Trabattoni, D., Villa, M. L., Salvaggio, A., Clerici, E., Clerici, M. (1996) Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 106, 127-133.
4. Bowen, J. M., Chamley, L., Mitchell, M. D., Keelan, J. A. (2002) Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 23, 239-256.
5. Hunt, J. S., Robertson, S. A. (1996) Uterine macrophages and environmental programming for pregnancy success. J. Reprod. Immunol. 32, 1-25.
6. Vince, G. S., Starkey, P. M., Jackson, M. C., Sargent, I. L., Redman, C. W. (1990) Flow cytometric characterisation of cell populations in human pregnancy decidua and isolation of decidual macrophages. J. Immunol. Methods 132, 181-189.
7. Hunt, J. S., Petroff, M. G., Burnett, T. G. (2000) Uterine leukocytes: key players in pregnancy. Semin. Cell Dev. Biol. 11, 127-137.
8. Veith, G. L., Rice, G. E. (1999) Interferon γ expression during human pregnancy and in association with labour. Gynecol. Obstet. Invest. 48, 163-167.
9. Ishitani, A., Geraghty, D. E. (1992) Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc. Natl. Acad. Sci. USA 89, 3947-3951.
10. Fujii, T., Ishitani, A., Geraghty, D. E. (1994) A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J. Immunol. 153, 5516-5524.
11. Le Gal, F. A., Riteau, B., Sedlik, C., Khalil-Daher, I., Menier, C., Dausset, J., Guillet, J. G., Carosella, E. D., Rouas-Freiss, N. (1999) HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 11, 1351-1356.
12. Kapasi, K., Albert, S. E., Yie, S., Zavazava, N., Librach, C. L. (2000) HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 101, 191-200.
13. Fournel, S., Aguerre-Girr, M., Huc, X., Lenfant, F., Alam, A., Toubert, A., Bensussan, A., Le Bouteiller, P. (2000) Cutting edge: soluble HLA-G triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J. Immunol. 164, 6100-6104.
14. Morales, P. J., Pace, J. L., Platt, J. S., Phillips, T. A., Morgan, K., Fazleabas, A. T., Hunt, J. S. (2003) Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J. Immunol. 171, 6215-6224.
15. Borges, L., Hsu, M. L., Fanger, N., Kubin, M., Cosman, D. (1997) A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 159, 5192-5196.
16. Petroff, M. G., Sedlmayr, P., Azzola, D., Hunt, J. S. (2002) Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules. J. Reprod. Immunol. 56, 3-17.
17. James, S. P. (1994) Measurement of proliferative responses of cultured lymphocytes. In Current Protocols in Immunology, vol. 1 (J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, W. Strober, eds.), Hoboken, NJ, John Wiley & Sons, 7.10.5.
18. Nandan, D., Reiner, N. E. (1997) TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. J. Immunol. 158, 1095-1101.
19. Musso, T., Calosso, L., Zucca, M., Millesimo, M., Ravarino, D., Giovarelli, M., Malavasi, F., Ponzi, A. N., Paus, R., Bulfone-Paus, S. (1999) Human monocytes constitutively express membrane-bound, biologically active, and interferon-γ-upregulated interleukin-15. Blood 93, 3531-3539.
20. Ishizuka, T., Hirata, I., Adachi, M., Kurimoto, F., Hisada, T., Dobashi, K., Mori, M. (1995) Effects of interferon-γ on cell differentiation and cytokine production of a human monoblast cell line, U937. Inflammation 19, 627-636.
21. Allan, D. S., Colonna, M., Lanier, L. L., Churakova, T. D., Abrams, J. S., Ellis, S. A., McMichael, A. J., Braud, V. M. (1999) Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 189, 1149-1156.
22. Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S., Makadzange, A., Rowland-Jones, S., Willcox, B., Jones, E. Y., van der Merwe, P. A., Kumagai, I., Maenaka, K. (2003) Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100, 8856-8861.
23. Vrana, J. A., Saunders, A. M., Chellappan, S. P., Grant, S. (1998) Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937). Differentiation 63, 33-42.
24. Chabot, S., Charlet, W., Wilson, T. L., Yong, V. W. (2001) Cytokine production consequent to T cell-microglia interaction: the PMA/IFN γ-treated U937 cells display similarities to human microglia. J. Neurosci. Methods 105, 111-120.
25. Rebmann, V., Pfeiffer, K., Passler, M., Ferrone, S., Maier, S., Weiss, E., Grosse-Wilde, H. (1999) Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 53, 14-22.
26. Hunt, J. S., Jadhav, L., Chu, W., Geraghty, D. E., Ober, C. (2000) Soluble HLA-G circulates in maternal blood during pregnancy. Am. J. Obstet. Gynecol. 183, 682-688.
27. Pfeiffer, K. A., Rebmann, V., Passler, M., van der Ven, K., van der Ven, H., Krebs, D., Grosse-Wilde, H. (2000) Soluble HLA levels in early pregnancy after in vitro fertilization. Hum. Immunol. 61, 559-564.
28. Rebmann, V., van der Ven, K., Passler, M., Pfeiffer, K., Krebs, D., Grosse-Wilde, H. (2001) Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 57, 15-21.
29. Contini, P., Ghio, M., Poggi, A., Filaci, G., Indiveri, F., Ferrone, S., Puppo, F. (2003) Soluble HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur. J. Immunol. 33, 125-134.
30. Le Friec, G., Laupeze, B., Fardel, O., Sebti, Y., Pangault, C., Guilloux, V., Beauplet, A., Fauchet, R., Amiot, L. (2003) Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum. Immunol. 64, 752-761.
31. Riteau, B., Menier, C., Khalil-Daher, I., Sedlik, C., Dausset, J., Rouas-Freiss, N., Carosella, E. D. (1999) HLA-G inhibits the allogeneic proliferative response. J. Reprod. Immunol. 43, 203-211.
32. Bainbridge, D. R., Ellis, S. A., Sargent, I. L. (2000) HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J. Reprod. Immunol. 48, 17-26.
33. Lila, N., Rouas-Freiss, N., Dausset, J., Carpentier, A., Carosella, E. D. (2001) Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc. Natl. Acad. Sci. USA 98, 12150-12155.
34. Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Weiss, E. H., Dichgans, J., Lochmuller, H., Hohlfeld, R., Melms, A., Weller, M. (2003) The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Brain 126, 176-185.
35. Clement, L. T. (1992) Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation. J. Clin. Immunol. 12, 1-10.
36. Trowbridge, I. S., Thomas, M. L. (1994) CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12, 85-116.
37. Heikkinen, J., Mottonen, M., Komi, J., Alanen, A., Lassila, O. (2003) Phenotypic characterization of human decidual macrophages. Clin. Exp. Immunol. 131, 498-505.
38. Roth, I., Corry, D. B., Locksley, R. M., Abrams, J. S., Litton, M. J., Fisher, S. J. (1996) Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J. Exp. Med. 184, 539-548.
39. Roth, I., Fisher, S. J. (1999) IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev. Biol. 205, 194-204.
40. Nakamura, K., Kitani, A., Fuss, I., Pedersen, A., Harada, N., Nawata, H., Strober, W. (2004) TGF-β 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol. 172, 834-842.
41. Stassen, M., Schmitt, E., Jonuleit, H. (2004) Human CD(4+)CD(25+) regulatory T cells and infectious tolerance. Transplantation 77, S23-S25.
42. Letterio, J. J., Roberts, A. B. (1998) Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16, 137-161.
43. Prud'homme, G. J., Piccirillo, C. A. (2000) The inhibitory effects of transforming growth factor-β-1 (TGF-β1) in autoimmune diseases. J. Autoimmun. 14, 23-42.
44. Huynh, M. L., Fadok, V. A., Henson, P. M. (2002) Phosphatidylserine- dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest. 109, 41-50.
45. Meisser, A., Chardonnens, D., Campana, A., Bischof, P. (1999) Effects of tumour necrosis factor-α, interleukin-1 α, macrophage colony stimulating factor and transforming growth factor β on trophoblastic matrix metalloproteinases. Mol. Hum. Reprod. 5, 252-260.
46. Ingman, W. V., Robertson, S. A. (2002) Defining the actions of transforming growth factor β in reproduction. Bioessays 24, 904-914.
47. Watson, A. L., Palmer, M. E., Burton, G. J. (1996) An in vitro model for the study of wound healing in first trimester human placenta. Cell Tissue Res. 286, 431-438.
48. Cox, D. A., Maurer, T. (1997) Transforming growth factor-β. Clin. Immunol. Immunol. Immunopathol. 83, 25-30.
49. Ashcroft, G. S. (1999) Bidirectional regulation of macrophage function by TGF-β. Microbes Infect. 1, 1275-1282.
50. Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P. Samaridis, J., Angman, L., Cella, M., Lopez-Botet, M. (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186, 1809-1818.
51. Colonna. M., Samaridis, J., Cella, M., Angman, L., Allen, R. L., O'Callaghan, C. A., Dunbar, R., Ogg, G. S., Cerundolo, V., Rolink, A. (1998) Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class 1 molecules. J. Immunol. 160, 3096-3100.
52. Fanger, N. A., Cosman, D., Peterson, L., Braddy, S. C., Maliszewski, C. R., Borges, L. (1998) The MHC class 1 binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 28, 3423-3434.
53. Navarro, F., Llano, M., Bellon, T., Colonna, M., Geraghty, D. E., Lopez-Botet, M. (1999) The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29, 277-283.
54. Chapman, T. L., Heikeman, A. P., Bjorkman, P. J. (1999) The inhibitory receptor LIR-1 uses a common binding interaction to recognize class 1 MHC molecules and the viral homolog UL18. Immunity 11, 603-613.